These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23466959)

  • 21. Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout.
    Graham GG; Stocker SL; Kannangara DRW; Day RO
    Curr Rheumatol Rep; 2018 Jun; 20(8):47. PubMed ID: 29931553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of complex gout in clinical practice: Update on therapeutic approaches.
    Narang RK; Dalbeth N
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):813-834. PubMed ID: 31427057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Something Old, Something New: the ACR Gout Treatment Guideline and Its Evolution from 2012 to 2020.
    Cohen RE; Pillinger MH; Toprover M
    Curr Rheumatol Rep; 2020 Nov; 23(1):4. PubMed ID: 33245444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations.
    Roddy E; Zhang W; Doherty M
    Ann Rheum Dis; 2007 Oct; 66(10):1311-5. PubMed ID: 17504843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging therapies for gout.
    Edwards NL; So A
    Rheum Dis Clin North Am; 2014 May; 40(2):375-87. PubMed ID: 24703353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stopping progression to tophaceous gout. When and how to use urate-lowering therapy.
    McDonald E; Marino C
    Postgrad Med; 1998 Dec; 104(6):117-20, 123-4, 127. PubMed ID: 9861261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New medications in development for the treatment of hyperuricemia of gout.
    Diaz-Torné C; Perez-Herrero N; Perez-Ruiz F
    Curr Opin Rheumatol; 2015 Mar; 27(2):164-9. PubMed ID: 25603039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lesinurad for the treatment of hyperuricaemia in people with gout.
    Robinson PC; Dalbeth N
    Expert Opin Pharmacother; 2017 Dec; 18(17):1875-1881. PubMed ID: 29103339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic approaches in the treatment of gout.
    Pillinger MH; Mandell BF
    Semin Arthritis Rheum; 2020 Jun; 50(3S):S24-S30. PubMed ID: 32620199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing your patient with gout: a review of treatment options.
    Doghramji PP
    Postgrad Med; 2011 May; 123(3):56-71. PubMed ID: 21566416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence and persistence to urate-lowering therapies in the Irish setting.
    McGowan B; Bennett K; Silke C; Whelan B
    Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.
    Perez-Ruiz F; Alonso-Ruiz A; Calabozo M; Herrero-Beites A; García-Erauskin G; Ruiz-Lucea E
    Ann Rheum Dis; 1998 Sep; 57(9):545-9. PubMed ID: 9849314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New and Pipeline Drugs for Gout.
    Keenan RT; Schlesinger N
    Curr Rheumatol Rep; 2016 Jun; 18(6):32. PubMed ID: 27097819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal arthropathies: recognizing and treating "the gouch".
    Quillen DM
    Prim Care; 2010 Dec; 37(4):703-11, v. PubMed ID: 21050952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The current state of care in gout: Addressing the need for better understanding of an ancient disease.
    Zychowicz ME; Pope RS; Graser E
    J Am Acad Nurse Pract; 2010 Nov; 22 Suppl 1():623-36. PubMed ID: 21054636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refractory gout: what is it and what to do about it?
    Fels E; Sundy JS
    Curr Opin Rheumatol; 2008 Mar; 20(2):198-202. PubMed ID: 18349751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of management of gout: a comparison of recent guidelines.
    Khanna PP; FitzGerald J
    Curr Opin Rheumatol; 2015 Mar; 27(2):139-46. PubMed ID: 25611299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of care in patients with gout: why is management suboptimal and what can be done about it?
    Edwards NL
    Curr Rheumatol Rep; 2011 Apr; 13(2):154-9. PubMed ID: 21161617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gout in 2006: the perfect storm.
    Terkeltaub R
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):82-6. PubMed ID: 17121496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gout: why is this curable disease so seldom cured?
    Doherty M; Jansen TL; Nuki G; Pascual E; Perez-Ruiz F; Punzi L; So AK; Bardin T
    Ann Rheum Dis; 2012 Nov; 71(11):1765-70. PubMed ID: 22863577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.